Clinical Trial: Non-Invasive Neuromodulation for Essential Tremor: Long-Term Safety and Effectiveness Study

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774598) titled 'Non-Invasive Neuromodulation for Essential Tremor: Long-Term Safety and Effectiveness Study' on March 22.

Brief Summary: This is a prospective, single-center, single-arm, open-label clinical study designed to evaluate the long-term efficacy and safety of non-invasive neuromodulation using transcutaneous afferent patterned stimulation (TAPS) in patients with essential tremor (ET).

Essential tremor is a common movement disorder that can significantly impair daily functioning and quality of life. Pharmacological treatments are often limited by suboptimal efficacy or adverse effects, highlighting the need for alternative therapeutic ap...